Microvascular flap reconstruction by otolaryngologists: prevalence, postoperative care, and monitoring techniques.
Cross-sectional survey published in The Laryngoscope (2007)
Abstract
BACKGROUND/OBJECTIVES: Microvascular "free flap" transplants have become the preferred method of reconstruction for a great variety of complicated head and neck defects. As recently as 10 years ago, having a microvascular surgeon within a department of otolaryngology was the exception rather than the rule, whereas it is our impression that today most academic programs have one or more microvascularly trained head and neck surgeons. Among microvascular surgeons, postoperative care and management regimens vary greatly. Through informal conversations, we discerned that some surgeons take a very aggressive approach to monitoring, perhaps including prolonged stays in an intensive care setting with implanted Doppler devices to monitor flap blood flow and intravenous administration of dextran or other pharmaceutical projects. Others report that patients are quickly discharged from the hospital after just aspirin and subcutaneous heparin for a few days. Some physicians perform "flap checks" hourly, whereas others have residents check only once daily. DESIGN/METHODS: We surveyed academic otolaryngology-head and neck surgery departments that sponsor residency programs in the United States to 1) determine the prevalence of microvascular trained otolaryngologists within training programs and 2) assess variations in postoperative and monitoring regimens. RESULTS: We found that on average, 12.2% of otolaryngologists per department perform free flap transplants, and 71.6% of microvascular trained surgeons continue to do free flaps. The surgeons self reported a 96.4% average success rate and a 6.88% return rate to the operating room for complications. Monitoring methods used included flap color (used by 79.4% of surgeons), Doppler signal (79.4%), pin prick and bleeding rate (67.6%), capillary refill (61.8%), skin surface temperature (11.8%), and implanted Doppler (8.8%). Anticoagulants used included aspirin (used by 76.5% of microvascular surgeons), low-molecular-weight dextran (35.3%), and subcutaneous heparin (26.5%). CONCLUSIONS: Microvascular training has become commonplace in otolaryngology-head and neck surgery training programs, with more than one in eight of these academic physicians reporting microvascular training. There was no self-reported difference in flap failure rates on the basis of postoperative care and monitoring regimen. The results of this survey suggest that a simplified consensus postoperative regimen can be recommended.
Abstract aus PubMed (NCBI) für den zitierten Eintrag, in der Originalsprache wiedergegeben. Maßgeblich ist die Fassung der Originalpublikation.
Das Abstract wird nicht übersetzt, damit die eigene Wortwahl der Autoren erhalten bleibt.
Zusammenfassung
Survey of US academic otolaryngology programs found 12.2% of otolaryngologists perform free flaps, self-reported success averaged 96.4%, and postoperative monitoring and anticoagulation regimens varied widely without differences in flap failure rates.
Warum dies für die Hirudotherapie relevant ist
Diese umfragebasierte Übersichtsarbeit bewertete die Prävalenz mikrovaskulären Trainings unter akademischen Abteilungen für Hals-Nasen-Ohren-Heilkunde und Kopf-Hals-Chirurgie in den Vereinigten Staaten und dokumentierte Variationen in der postoperativen Versorgung und in Überwachungsregimen für freie Lappenplastiken. Die Studie ergab, dass im Durchschnitt 12,2 % der HNO-Chirurgen pro Abteilung freie Lappenplastiken durchführen, mit einer selbstberichteten durchschnittlichen Erfolgsrate von 96,4 %, und identifizierte diverse Überwachungsmethoden (Lappenfarbe, Doppler-Signal, Stichinzision) sowie Antikoagulationspraktiken (Aspirin 76,5 %, niedermolekulares Dextran 35,3 %, subkutanes Heparin 26,5 %). Für ASHs Domäne ist dies tangential relevant, da die mikrovaskuläre freie Lappenplastik ein klinisches Setting darstellt, in dem medizinische Blutegel gelegentlich adjuvant bei venöser Kongestion eingesetzt werden. Caveat: Das Abstract erwähnt weder Blutegel noch Hirudotherapie; die Relevanz ist rein kontextbezogen zur chirurgischen Umgebung, in der Blutegeltherapie zur Anwendung kommen kann, und es wurden keine Daten zur Blutegelanwendung erhoben.
Zitation
Microvascular flap reconstruction by otolaryngologists: prevalence, postoperative care, and monitoring techniques.
Spiegel et al. · The Laryngoscope, 2007
Verwandter klinischer Kontext
Erfahren Sie, wie diese Forschung mit der klinischen Praxis verknüpft ist
Verwandte Forschungsarbeiten
Weitere begutachtete Studien in der Kategorie „Klinische Studien“.
- Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
- Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
- Auswirkungen der Hirudotherapie auf Leberfunktionen, Lipidprofil und Insulinsensitivität bei Ratten mit metabolischem Syndrom — Bilden A et al. (2026)
- Efficacy and Safety of Hirudotherapy for Improving Sperm Quality Parameters in Male Infertility: A Randomized Controlled Trial — Abtahi-Forooshani M et al. (2026)
- Reverse Sural Flap Venous Congestion Successfully Managed With Enoxaparin in a Male Patient With a Traumatic Foot Crush Injury: A Case Report — Velasco-Bustamante J et al. (2026)
- Investigation of the therapeutic effects of medicinal leech treatment on lower extremity ischemia-reperfusion injury — Ünal K et al. (2026)
- Wirksamkeit der Therapie mit medizinischen Blutegeln bei unterschiedlichen klinischen Anwendungen: Eine umfassende Studie aus Aserbaidschan — Farzali S et al. (2025)
- HIRUDOTHERAPY IN RECONSTRUCTIVE SURGERY: CASE-REPORTS AND REVIEW — Heinz P et al. (2020)
- Hirudotherapy in Wound Healing — Nair H et al. (2022)
- Improvement of patient care through hirudotherapy and the management of leeches from their reception to their disposal in France — Vaesken C et al. (2023)
Zur ASH-Bibliothek hinzugefügt: 28. Mai 2026 · Letzte Aktualisierung der Website: 18. Juni 2026